海南赞邦制药有限公司
100-499人
公司优势
Zambon S.p.A, a global leader in pharmaceuticals and chemicals, was founded in Vicenza, Italy in 1906. Through a century of growth marked by continuous innovation, adaptable business strategies, and customer-centric values, the company has ascended to the ranks of the world's premier pharmaceutical firms. Today, Zambon operates across 16 nations, holding a dominant position in respiratory system antioxidant therapy and urinary system antimicrobial treatments.
In 1998, Zambon established Hainan Zambon Pharmaceutical Co., Ltd in China. Over the last two decades, this subsidiary has made significant strides. By 2000, it had secured national GMP certification and implemented an advanced fully automated granulation process. Leveraging the robust R&D capabilities of its parent company, Hainan Zambon's product portfolio encompasses treatments for respiratory conditions, urinary issues, endocrine disorders, and cardiovascular ailments. In 2007, it underwent a rigorous inspection by AIFA, Italy's regulatory body, and earned EU GMP certification, making it the first pharmaceutical firm in Hainan to achieve this distinction.
As Zambon looks ahead, it intends to uphold its legacy of excellence in medical research and global expansion, striving to enhance human well-being worldwide. Meanwhile, Hainan Zambon plans to harness the strengths of its parent corporation to introduce cutting-edge products to China, offering unparalleled services that contribute to healthier living experiences.
In 1998, Zambon established Hainan Zambon Pharmaceutical Co., Ltd in China. Over the last two decades, this subsidiary has made significant strides. By 2000, it had secured national GMP certification and implemented an advanced fully automated granulation process. Leveraging the robust R&D capabilities of its parent company, Hainan Zambon's product portfolio encompasses treatments for respiratory conditions, urinary issues, endocrine disorders, and cardiovascular ailments. In 2007, it underwent a rigorous inspection by AIFA, Italy's regulatory body, and earned EU GMP certification, making it the first pharmaceutical firm in Hainan to achieve this distinction.
As Zambon looks ahead, it intends to uphold its legacy of excellence in medical research and global expansion, striving to enhance human well-being worldwide. Meanwhile, Hainan Zambon plans to harness the strengths of its parent corporation to introduce cutting-edge products to China, offering unparalleled services that contribute to healthier living experiences.
热招职位
RX临床销售代表(成都)8千-1万
成都大专及以上经验不限
医药销售代表(OTC)8千-1万
中山大专及以上经验不限
RX地区经理(郑州)1.5-2万
郑州本科及以上经验不限
电商渠道经理1.5-2.5万
上海本科及以上经验不限
医药销售代表(临床)8千-1万
湘潭大专及以上经验不限
RX临床医药代表(无锡)8千-1万
无锡大专及以上经验不限
RX临床销售代表(长春)8千-1万
长春大专及以上经验不限
RX临床销售代表(青岛)8千-1万
青岛大专及以上经验不限
Rx临床销售代表(哈尔滨)8千-1万
哈尔滨大专及以上经验不限
RX临床医药代表(上海)8千-1万
上海大专及以上经验不限
相关职位
地区经理-戊肝疫苗线20-35万/年
中山大专及以上经验不限
区域经理15-25万/年
中山本科及以上经验不限
地区经理1.2-2万
中山大专及以上经验不限
区域经理1.1-1.3万
中山大专及以上经验不限
豆果产品区域经理(中山)7千-1万
中山学历不限经验不限
综发-区域经理面议
中山本科及以上3-5年
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位,每周送达
🎉恭喜你,订阅成功
继续订阅
您可以在邮箱中随时取消订阅
